Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00000915 · ClinicalTrials.gov registry record · NA
An HIV Vaccine Preparedness Study
A NA study, sponsored by National Institute of Allergy and Infectious Diseases (NIAID).
- Completed
- Registry status
- NA
- Development phase
- 4,892
- Enrollment target
NCT00000915 is a NA study that has completed, run by National Institute of Allergy and Infectious Diseases (NIAID). The registered enrollment target is 4,892 participants.
The verdict
NCT00000915, a NA study, has completed, sponsored by National Institute of Allergy and Infectious Diseases (NIAID).
- COMPLETED
- Registry status
- NA
- Development phase
- 4,892 participants
- Enrollment target
Study Summary
The purpose of this study is to estimate the rate at which a certain population becomes infected with HIV. The individuals examined in this study are people who are expected to take part in future studies of HIV vaccines and nonvaccine HIV prevention studies. This study also examines the chances of becoming HIV-positive based on certain risk factors under conditions that are similar to the conditions that would exist in HIV vaccine and non-HIV prevention studies. Before studying the effectiveness of a potential HIV vaccine, it is important to learn about the range of HIV risk behaviors in the potential participants of these studies. The probability of HIV infection associated with these risk behaviors should also be examined. This study is designed to increase the ability of HIVNET to put into place HIV prevention trials, to increase the diversity of trial participants, and to target populations at highest risk for HIV infection.
Interventions
- BEHAVIORAL Vaccine preparedness
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 4,892 participants |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00000915
The ClinicalTrials.gov registry entry for NCT00000915 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 4,892 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is National Institute of Allergy and Infectious Diseases (NIAID), which has 2,006 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Vaccine preparedness is the first listed.
NCT00000915 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00000915 about?
NCT00000915 is a clinical study titled "An HIV Vaccine Preparedness Study". The purpose of this study is to estimate the rate at which a certain population becomes infected with HIV. The individuals examined in this study are people who are expected to take part in future studies of HIV vaccines and nonvaccine HIV prevention studies. This study also examines the chances of ...
What is the current status of trial NCT00000915?
This trial is currently completed. It is a NA study. The enrollment target is 4,892 participants.
What interventions are being tested in trial NCT00000915?
The interventions under investigation include: Vaccine preparedness (BEHAVIORAL).
Who is sponsoring clinical trial NCT00000915?
This trial is sponsored by National Institute of Allergy and Infectious Diseases (NIAID), which has 2,006 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.